Form 485BPOS LAZARD RETIREMENT SERIES
Tweet
Share
E-mail
http://archive.fast-edgar.com/20160519/AK2ZT222Z222E2ZZ2F2C2C38MUPPZ322ZR82
Filed on: May 19, 2016
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Incyte acquires Vega Therapeutics for $1.25B upfront
- Zymeworks to acquire Theravance Biopharma for $17 per share
- Zymeworks to buy Theravance Biopharma for $17 per share
Create E-mail Alert Related Categories
SEC FilingsRelated Entities
LazardSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
